Nephrotoxicity Risk of Cyclophosphamide in Lupus Model
Cyclophosphamide is one of the standard therapies for lupus, especially lupus nephritis based on its immunosuppressive effect. However, cyclophosphamide is also known as a nephrotoxic agent. Therefore, this research was aimed to measure the effect of cyclophosphamide at the dose that comparable to t...
Main Author: | Niken Indriyanti |
---|---|
Format: | Article |
Language: | English |
Published: |
Mulawarman University
2021-06-01
|
Series: | Journal of Tropical Pharmacy and Chemistry |
Subjects: | |
Online Access: | https://jtpc.farmasi.unmul.ac.id/index.php/jtpc/article/view/289 |
Similar Items
-
Ameliorative effects of hydroalcoholic extract of Lavandula officinalis L. on cyclophosphamide-induced nephrotoxicity in mice
by: Ali Sadeghi, et al.
Published: (2017-10-01) -
Fish oil enhanced the efficacy of low-dose cyclophosphamide regimen for proliferative lupus nephritis: a randomized controlled double-blind trial
by: Chi Zhang, et al.
Published: (2021-07-01) -
Efficacy and safety of belimumab/low-dose cyclophosphamide therapy in moderate-to-severe systemic lupus erythematosus
by: Hao Cheng, et al.
Published: (2022-08-01) -
Premature ovarian failure in systemic lupus erythematosus patients: is it related to cyclophosphamide treatment?
by: Rasha M Ghaleb, et al.
Published: (2019-01-01) -
TO COMPARE THE EFFICACY OF MYCOPHENOLATEMOFETYL WITH CYCLOPHOSPHAMIDE IN THE MANAGEMENT OF LUPUS NEPHRITIS
by: Dilshad Muhammad, et al.
Published: (2014-12-01)